Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Slides:



Advertisements
Similar presentations
Summary Prepared by Melvyn Rubenfire, MD
Advertisements

Robert M. Guthrie, MD Professor of Emergency Medicine
Ronald A. Codario, MD Assistant Clinical Professor of Medicine
Metabolic & Endocrine Disease Summit Dyslipidemia and Current Guidleines for Lipid Management Thursday July 28, 2011 Orlando, FL Joyce L. Ross, MSN, CRNP,
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Detection and Treatment of Asymptomatic Atherosclerosis for Primary Prevention.
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
R Dhangana, TP Murphy, MJ Pencina, MB Ristuccia, JV Cerezo, D Tsai Prevalence of Low Ankle-Brachial Index, Elevated Plasma Fibrinogen and CRP Among Those.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
ADVICE. Advice Strongly advise adherence to diet and medication Smoking cessation, exercise, weight reduction Ensure diabetes education and advise Diabetes.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Morteza Naghavi, M.D. Founder Society for Heart Attack Prevention and Eradication (SHAPE) SHAPE Guidelines Prevention of Fatal Cardiovascular Events (Heart.
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
 #1 health concern in USA  38% of all deaths  1 in 2.7 Americans die from CVD  80 million Americans suffer from some form of CVD  Lower educational.
השמנת יתר חמד " ע פרופ ' ארדון רובינשטין.
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
How To Be Healthy Without Killing Yourself B Bottenberg, D.O., FNLA, FACOI.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Global impact of ischemic heart disease World Heart Federation, 2011.
LDL-C target levels (mg/dL)  2 RF:
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
RISK FACTOR FOR CORONARY ARTERY DISEASE
METABOLIC Syndrome: a Global Perspective
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
Obesity, Metabolic Syndrome and Diabetes in Hispanics: implications on Cardiovascular Disease 2011 Eduardo de Marchena M.D., F.A.C.C., F.A.C.P. Professor.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Diabetes National Diabetes Control Programme
VBWG Insulin Resistance and Cardiovascular Disease: New Perspectives From Vascular Biology.
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Houston, TX Screening for Early Detection and Prevention of Heart Attack.
Impact of Diabetes on Cardiovascular Risk C.Richard Conti M.D. MACC Oct 16,2004 GWICC Beijing, PRC.
Slide Source: Lipids Online Slide Library C-Reactive Protein, Metabolic Syndrome, and Risk for CV Events: Women’s Health Study 14,719.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
Abstract The metabolic syndrome (MetS) has surpassed smoking as the number one cause of cardiovascular deaths in the US. However, it remains under diagnosed.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Application of the Screening for Heart Attack Prevention.
The role of unknown risk factors in coronary heart disease
CVD Part 2.
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
Type 2 diabetes: Overlap of clinical conditions
Level of risk factor control in the overall sample and by gender
Goals & Guidelines A summary of international guidelines for CHD
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Requested Information by CMS Team During April 30th Hearing
Presentation transcript:

Only You Can Prevent CVD Matthew Johnson, MD

What can we do to prevent CVD?

What can WE do to save the most lives?

What risk factors are important in the development of heart disease?

Who is at risk and how can we calculate risk?

Background: Clinical guidelines for primary prevention of CAD recommend a risk management based on the Framingham score.

Screening for early detection of high risk patients with asymptomatic atherosclerosis and monitoring their response to treatments in order to reduce sudden cardiovascular events remain as major challenges in preventive cardiology.

Background: Cont. Traditional tools used to assign risk of future cardiovascular events, at times fail to accurately identify individuals with severe coronary artery disease. Despite major advances in the treatment of coronary artery disease (CAD), a large number of apparently healthy people die suddenly of a heart attack without prior symptoms and do not benefit from existing preventive therapies.

Background: Cont. The Framingham score as applied in these guidelines is a tool to predict the absolute risk of coronary events in populations free of cardiovascular disease. Reynolds risk score is also a tool to predict the risk of coronary events.

Framingham risk score (FRS) Framingham Risk Score (FRS) is calculated based on NCEP ATP III ( age, gender, total cholesterol, HDL-C, Smoking status, Systolic blood Pressure and Anti- hypertensive medication)

Results: Cont.

Role of Vascular and Neurovascular Function in Cardiovascular Disease Vascular dysfunction is generally considered a key initial event in the atherosclerotic process which is a local manifestation of systemic disorder. Numerous studies have shown that functional changes in arteries precede the development of structural changes and also reverse more quickly in response to therapies

What is a calcium score? A calcium score refers to a screening test that is used to calculate the amount of calcium in the heart. A calcium score looks specifically at calcium in the coronary arteries, where increased calcium leads to narrowing of the artery.

How is a CCS calculated? The calcium score is calculated from Computed Tomography (CT) scan images. The two main types of CT scanners are "Electron Beam" (EBCT) and "Multi- Detector" (MDCT). Both types of scanners are generally effective in calculating a calcium score.

What is the purpose of a Calcium Score? The purpose of a calcium score is to determine if a patient is at high risk for coronary artery disease, which may lead to a heart attack. In general, a high calcium score is associated with a higher risk of cardiovascular events, while a calcium score of zero is associated with a very low risk of coronary artery disease or heart attack.

Public Enemy #1

Diabetes Prevalence,

Risk of Cardiovascular Events in Diabetics Framingham Study Age-adjusted Biennial Rate Age-adjusted Per 1000 Risk Ratio Cardiovascular Event Men Women Men Women Coronary Disease ** 2.2*** Stroke *** 2.6*** Peripheral Artery Dis *** 6.4*** Cardiac Failure *** 7.8*** All CVD Events *** 3.7*** Subjects year Follow-up **P<.001,***P<.0001 _________________________________________________________________

Insulin Resistance

Natural History of Type 2 Diabetes

Relationship Between Obesity and Insulin Resistance and Dyslipidemia

Insulin Resistance: Associated Conditions

Cardiovascular Disease and Diabetes

Probability of Death From CHD in Patients With Type 2 Diabetes With or Without Previous MI

The Metabolic Syndrome Insulin Resistance Hypertension Type 2 Diabetes Disordered Fibrinolysis Complex Dyslipidemia TG, LDL HDL Endothelial Dysfunction Systemic Inflammation Athero- sclerosis Visceral Obesity Adapted from the ADA. Diabetes Care. 1998;21: ; Pradhan AD et al. JAMA. 2001;286:

Revised ATP III Metabolic Syndrome Oct 2005 *Diagnosis is established when  3 of these risk factors are present. † Abdominal obesity is more highly correlated with metabolic risk factors than is  BMI. ‡ Some men develop metabolic risk factors when circumference is only marginally increased. <40 mg/dL <50 mg/dL or Rx for ↓ HDL Men Women >102 cm (>40 in) >88 cm (>35 in) Men Women  100 mg/dL or Rx for ↑ glucose Fasting glucose  130/  85 mm Hg or on HTN Rx Blood pressure HDL-C  150 mg/dL or Rx for ↑ TG TG Abdominal obesity † (Waist circumference ‡ ) Defining LevelRisk Factor

International Diabetes Federation Definition: Abdominal obesity plus two other components: elevated BP, low HDL, elevated TG, or impaired fasting glucose

Prevalence of the Metabolic Syndrome Among US Adults NHANES Prevalence (%) > 70 Men Women Age (years) Ford E et al. JAMA. 2002(287): Prevalence by IDF vs. NCEP Definitions (Ford ES, Diabetes Care 2005; 28: ) (unadjusted, age 20+) NCEP : 33.7% in men and 35.4% in women IDF: 39.9% in men and 38.1% in women